Figshare
open access
CC BY 4.0
Toward Precision Antipsychotic Prescribing: Development of a Ki–DDD–TWAS Lipid-Metabolic Liability Index
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics#314308
- Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults#346854
- Bromocriptine for Patients With Schizophrenia and Prediabetes#887270
- Assess the Safety, Tolerability, and Pharmacokinetics of HL-1186 in Healthy Participants#871107
- Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin#256857
Record · ID 304106
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive